Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease

Journal of Leukocyte Biology

Volumn 72, Issue 2, 2002, Pages 233-238

  Sue T Griffin, W ^a,b,c   Mrak, Robert E ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Brain; Down's syndrome; Epilepsy; Genetic risk; Head injury; Immunogenetics; Neurodegenerative disease

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA;

ALZHEIMER DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENE OVEREXPRESSION; GENETIC RISK; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; REVIEW;

ADULT; AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ASTROCYTES; BRAIN INJURIES; DISEASE PROGRESSION; DOWN SYNDROME; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; MICROGLIA; MIDDLE AGED; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; NEURONS; POLYMORPHISM, GENETIC; SENILE PLAQUES;

EID: 0036697305     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Griffin, W. S. T., Stanley, L. C., Ling, C., White, L., Macleod, V., Perrot, L. J., White III, C. L., Araoz, C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
2. Griffin, W. S. T., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E., Roberts, G. W. (1994) Microglial interleukin-1α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci. Lett. 176, 133-136.
3. Sheng, J. G., Boop, F. A., Mrak, R. E., Griffin, W. S. T. (1994) Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J. Neurochem. 63, 1872-1879.
4. Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S-X., Marshak, D. R., Nelson, S. J., Griffin, W. S. T. (1994) Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53, 231-238.
5. Mackenzie, I. R. A., Miller, L. A. (1994) Senile plaques in temporal lobe epilepsy. Acta Neuropathol. 87, 504-510.
6. Esiri, M. M., Biddolph, S. C., Morris, C. S. (1998) Prevalence of Alzheimer plaques in AIDS. J. Neurol. Neurosurg. Psychiatry 65, 29-33.
7. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., Somogyi, R. (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20, 683-695.
8. Nicoll, J. A. R., Mrak, R. E., Graham, D. I., Stewart, J., Wilcock, G., MacGowan, S., Esiri, M. M., Murray, L. S., Dewar, D., Love, S., Moss, T., Griffin, W. S. T. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47, 365-368.
9. Grimaldi, L. M. E., Casadei, V. M., Ferri, C., Veglia, F., Licastro, F., Annoni, G., Biunno, I., De Bellis, G., Sorbi, S., Mariani, C., Griffin, W. S. T., Franceschi, M. (2000) Association of early onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann. Neurol. 47, 361-365.
10. Du, Y., Dodel, R. C., Eastwood, B. J., Bales, K. R., Gao, F., Lohmüller, F., Müller, U., Kurz, A., Zimmer, R., Evans, R. M., Hake, A., Gasser, T., Oertel, W. H., Griffin, W. S. T., Paul, S. M., Farlow, M. R. (2000) Association of an interleukin 1α polymorphism with Alzheimer's disease. Neurology 55, 480-483.
11. Rebeck, G. W. (2000) Confirmation of the genetic association of IL-1α with early onset sporadic Alzheimer's disease. Neurosci. Lett. 293, 75-77.
12. Hedley, R., Hallmayer, J., Groth, D. M., Brooks, W. S., Gandy, S. E., Martins, R. N. (2002) Association of interleukin-1 polymorphisms with Alzheimer's disease in an Australian population. Ann. Neurol. 51, 795-797.
13. Minster, R. L., DeKosky, S. T., Ganguli, M., Belle, S., Kamboh, M. I. (2000) Genetic association studies of interleukin-1 (IL-1α and IL-1β) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann. Neurol. 48, 817-819.
14. Griffin, W. S. T., Sheng, J. G., Roberts, G. W., Mrak, R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54, 276-281.
15. Sheng, J. G., Mrak, R. E., Griffin, W. S. T. (1997) Glial-neuronal interactions in Alzheimer's disease: progressive association of IL-1α+ microglia and S100β+ astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56, 285-290.
16. Sheng, J. G., Jones, R. A., Zhou, X. Q., McGinness, J. M., Van Eldik, L. J., Mrak, R. E., Griffin, W. S. T. (2001) Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem. Int. 39, 341-348.
17. Wisniewski, K. E., Wisniewski, H. M., Wen, G. Y. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.
18. Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S. S., Potter, H., Nilsson, L. N. (1999) Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274, 6421-6431.
19. Buxbaum, J. D., Oishi, M., Chen, H. I., Pinkas-Kramarski, R., Jaffe, E. A., Gandy, S. E., Greengard, P. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
20. Forloni, G., Demicheli, F., Giorgi, S., Bendotti, C., Angeretti, N. (1992) Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 16, 128-134.
21. Giulian, D., Woodward, J., Young, D. G., Krebs, J. F., Lachman, L. B. (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8, 2485-2490.
22. Sheng, J. G., Ito, K., Skinner, R. D., Mrak, R. E., Rovnaghi, C. R., Van Eldik, L. J., Griffin, W. S. T. (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17, 761-766.
23. Kligman, D., Marshak, D. R. (1985) Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA 82, 7136-7139.
24. Sheng, J. G., Mrak, R. E., Griffin, W. S. T. (1994) S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39, 398-404.
25. Mrak, R. E., Sheng, J. G., Griffin, W. S. T. (1996) Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 273-279.
26. Sheng, J. G., Zhou, X. Q., Mrak, R. E., Griffin, W. S. T. (1998) Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 714-717.
27. Barger, S. W., Harmon, A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 28, 878-881.
28. Li, Y., Liu, L., Kang, J., Sheng, J. G., Barger, S. W., Mrak, R. E., Griffin, W. S. T. (2000) Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20, 149-155.
29. Lachman, L. B., Page, S. O., Metzgar, R. S. (1980) Purification of human interleukin 1. J. Supramol. Struct. 13, 457-466.
30. Smith, K. A., Lachman, L. B., Oppenheim, J. J., Favata, M. F. (1980) The functional relationship of the interleukins. J. Exp. Med. 151, 1551-1556.
31. Duff, G. (1985) Immune diseases. Many roles for interleukin-1. Nature 313, 352-353.
32. Fontana, A., Kristensen, F., Dubs, R., Gemsa, D., Weber, E. (1982) Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 gliomia cells. J. Immunol. 129, 2413-2419.
33. Li, Y., Wang, J., Sheng, J. G., Liu, L., Barger, S. W., Jones, R. A., Van Eldik, L. J., Mrak, R. E., Griffin, W. S. T. (1998) S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71, 1421-1428.
34. Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. G., Jacobsen, J. S., Vitek, M. P., Gajdusek, D. C. (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
35. Brenneman, D. E., Page, S. W., Schultzberg, M., Thomas, F. H., Zelazowski, P., Burnet, P., Avidor, R., Sternberg, E. M. (1992) A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J. Pharmacol. Exp. Ther. 266, 1029-1035.
36. Sheng, J. G., Zhu, S. G., Griffin, W. S. T., Mrak, R. E. (2000) Interleukin-1 promotes expression and phosphorylation of neurofilament and tau protein in vivo. Exp. Neurol. 163, 388-391.
37. Zhu, S. G., Sheng, J. G., Jones, R. A., Brewer, M. M., Zhou, X. Q., Mrak, R. E., Griffin, W. S. T. (1999) Increased interleukin-1β converting enzyme expression and activity in Alzheimer disease. J. Neuropathol. Exp. Neurobiol. 58, 582-587.
38. Chan, S. L., Griffin, W. S. T., Mattson, M. P. (1999) Evidence for Caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J. Neurosci. Res. 57, 315-323.
39. Sheng, J. G., Zhou, X. Q., Mrak, R. E., Griffin, W. S. T. (1998) Progressive neuronal injury associated with neurofibrillary tangle formation in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 57, 323-328.
40. Marshak, D. R., Pesce, S. A., Stanley, L. C., Griffin, W. S. T. (1991) Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging 13, 1-7.
41. Sheng, J. G., Mrak, R. E., Griffin, W. S. T. (1995) Interleukin-1β expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21, 290-301.
42. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Volk, B., Berger, M. (1991) Interleukin-6 and alpha2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
43. Das, S., Potter, H. (1995) Expression of the Alzheimer amyloid-promoting factors α1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron 14, 447-456.
44. Barnum, S. R., Jones, J. L. (1995) Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci. Lett. 197, 121-124.
45. McDowell, T. L., Symons, J. A., Ploski, R., Forre, O., Duff, G. W. (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38, 221-228.
46. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., Nerup, J. A. (1992) TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Investig. 22, 396-402.
47. Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., Mrak, R. E. (1998) Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8, 65-72.
48. Mayeux, R., Ottman, R., Tang, M. X., Noboa-Bauza, L., Marder, K., Gurland, B., Stern, Y. (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501.
49. Mortimer, J. A., van Duijn, C. M., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Rocca, W. A. (1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20, S28-S35.
50. Roberts, G. W., Allsop, D., Bruton, C. J. (1990) The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry 53, 373-378.
51. Roberts, G. W., Gentleman, S. M., Lynch, A., Graham, D. I. (1991) βA-4 Amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423
52. Roberts, G. W., Gentleman, S. M., Lynch, A., Murray, L., Landon, M., Graham, D. I. (1994) β-Amyloid protein deposition in the brain following severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 7, 419-425.
53. Nicoll, J. A. R., Roberts, G. W., Graham, D, I. (1995) Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1, 135-137.
54. Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M. X., Ginsberg, H., Chun, M., Tycko, B., Shelanski, M. (1995) Synergistic effects of traumatic head injury and apolipoprotein-E in patients with Alzheimer's disease. Neurology 45, 555-557.
55. McKenzie, J. E., Gentleman, S. M., Roberts, G. W., Graham, D. I., Royston, M. C. (1994) Increased numbers of βAPP-immunoreactive neurons in the entorhinal cortex after head injury. Neuroreport 6, 161-164.
56. Abe, K., Tanzi, R. E., Kogure, K. (1991) Selective induction of Kunitztype protease inhibitor domain containing β-APP mRNA after persistent focal ischaemia in rat cerebral cortex. Neurosci. Lett. 125, 172-174.
57. Pluta, R., Kida, E., Lossinsky, A. S., Golabak, A. A., Mossakowski, M. J., Wisniewski, H. M. (1994) Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res. 649, 323-328.
58. Gentleman, S. M., Graham, D. I., Roberts, G. W. (1993) Molecular pathology of head trauma: altered βAPP metabolism and the aetiology of Alzheimer's disease. Prog. Brain Res. 96, 237-246.
59. Sheng, J. G., Mrak, R. E., Griffin, W. S. T. (1998) Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24, 278-283.
60. Sheng, J. G., Mrak, R. E., Griffin, W. S. T. (1998) Enlarged and phagocytic, but not primed, IL-1α+ microglia increase with age in normal human brain. Acta Neuropathol. 94, 1-5.
61. Sheng, J. G., Mrak, R. E., Rovnaghi, C. R., Kozlowska, E., Van Eldik, L. J., Griffin, W. S. T. (1996) Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17, 359-363.
62. Griffin, W. S. T., Yeralan, O., Boop, F., Rovnaghi, C. R., Sheng, J. G., Mrak, R. E., Van Eldik, L. J. (1995) Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J. Neurochem. 65, 228-233.
63. Gouras, G. K., Relkin, N. R., Sweeney, D., Munoz, D. G., Mackenzie, I. R., Gandy, S. (1997) Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann. Neurol. 41, 402-404.
64. McDowell, T. L., Symons, J. A., Ploski, R., Forre, O., Duff, G. W. (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis Rheum. 38, 221-228.
65. Momiyama, Y., Hirano, R., Taniguchi, H., Nakamura, H., Ohsuzu, F. (2001) Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J. Am. Coll. Cardiol. 38, 712-717.
66. Kornman, K. S., Crane, A., Wang H-Y., di Giovine, F. S., Newman, M. G., Pirk, F. W., Wilson Jr., T. G., Higginbottom, F. L., Duff, G. W. (1997) The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 24, 72-77.
67. Donaldson, P., Agarwal, K., Craggs, A., Craig, W., James, O., Jones, D. (2001) HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 48, 397-402.
68. Kato, S., Onda, M., Yamada, S., Matsuda, N., Tokunaga, A., Matsukura, N. (2001) Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J. Gastroenterol. 36, 696-699.
69. Nemetz, A., Toth, M., Garcia-Gonzalez, M. A., Zagoni, T., Feher, J., Pena, A. S., Tulassay, Z. (2001) Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases. Gut 49, 644-649.
70. Zheng, C., Huang, D. R., Bergenbrant, S., Sundblad, A., Osterborg, A., Bjorkholm, M., Holm, G., Yi, Q. (2000) Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br. J. Haematol. 109, 39-45.
71. Wilkinson, R. J., Patel, P., Llewelyn, M., Hirsch, C. S., Pasvol, G., Snounou, G., Davidson, R. N., Toossi, Z. (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 189, 1863-1874.